Exacerbation of colitis and promotion of colitis associated cancer by environmental chemicals via modulation of T cell mediated immunity
Exacerbation of colitis and promotion of colitis associated cancer by environmental chemicals via modulation of T cell mediated immunity
批准号:
21510067
负责人:
KATO Takuma
金额:
$3.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
在这项研究中,一种重要的环境化学物质三丁基锡可能参与了结肠炎的恶化和结肠炎相关性结直肠癌的促进。使用偶氮甲烷和右旋糖胺钠盐诱导的结肠炎和结肠炎相关癌症的小鼠模型,我们发现暴露于环境相关剂量的三丁基锡加剧了结肠炎,并促进了结肠癌的诱导。我们还发现,在肿瘤出现之前,三丁基锡暴露显著增强了Th2细胞因子和下游激活诱导的胞苷脱氨酶的表达,这被称为自然突变因子。另一方面,过量表达内在抗氧化剂硫氧还蛋白的小鼠可以防止诱发结肠癌。此前,我们已经证明三丁基锡通过氧化应激促进Th2细胞分化,从而导致Th2免疫增强。综上所述,这些结果表明,三丁基锡调节Th免疫,导致AID表达增强,参与了结肠炎相关结直肠癌的加重和促进。
英文摘要
In the present study, the possible involvement of a prominent environmental chemical, tributyltin, in the exacerbation of colon inflammation and promotion colitis associated colorectal cancer was examined. Using a mouse model of azoxymethane and dexstran sodium salt induced colitis and colitis associated cancer, we found that exposure of an environmentally relevant dose of tributyltin exacerbated colon inflammation and promoted induction of colon cancer. We also found that the expression Th2 cytokines and downstream activation-induced cytidine deaminase that is know as natural mutator were significantly enhanced by tributyltin exposure before tumor emergence. On the other hand, mouse overexpressing intrinsic anti-oxidant, thioredoxin, was protected from the induction of colon cancer. Previously, we have shown that tributyltin promote Th2 cell differentiation that results in the enhancement of Th2 immunity through oxidative stress. Collectively, these results suggest that modulation of Th immunity by tributyltin that leads to the enhancement of AID expression is involved in the exacerbation of colon inflammation and promotion of colitis associated colorectal cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Augmentation of immune responses by molecules of immuno-modulators provides outstanding anti-tumor capacity.
免疫调节剂分子增强免疫反应可提供出色的抗肿瘤能力。
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[王立楠, 西川博嘉, 三井潤, 村岡大輔, 前出優香, 佐藤永一, 近藤哲, 加藤琢磨, 珠玖洋]
通讯作者:
珠玖洋
Effects of corticosteroids on tumor immunity induced by anti-CTLA-4 mAb therapy in a mouse model.
皮质类固醇对小鼠模型中抗 CTLA-4 mAb 治疗诱导的肿瘤免疫的影响。
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Maeda Y, Kato, T, Wang L, Muraoka D, Sato E, Wolchok JD, Old LJ, Shiku H, Nishikawa H]
通讯作者:
Nishikawa H
Distinct roles of II-17A in inflammation-induced tumor development and tumor immuno-surveillance
II-17A 在炎症诱导的肿瘤发展和肿瘤免疫监视中的独特作用
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[加藤琢磨, 西川博嘉, 王立楠, 三井潤, 前田優香, 珠玖洋]
通讯作者:
珠玖洋
UV-induce immune suppression that promotes skin cancer development and progression
紫外线诱导的免疫抑制可促进皮肤癌的发生和进展
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Kato, T., and L. Wang]
通讯作者:
and L. Wang
DOI:
10.2217/imt.11.26
发表时间:
2011-05
期刊:
Immunotherapy
影响因子:
2.8
作者:
[Takuma Kato]
通讯作者:
Takuma Kato
共 46 条
Therapeutic potintial of Tregs transduced with CEA specific CAR in sever asthma
-
批准号:16K09533
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2016
-
负责人:KATO Takuma
-
依托单位:
A paradigm shift in T cell adaptive cell therapy using Th1/Th17 cells transduced chimeric antigen receptor
-
批准号:25670553
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:KATO Takuma
-
依托单位:
Exacerbation of airway inflammation by environmental chemicals via suppression of CD4+CD25+ regulatory T cell function
-
批准号:18604004
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.67万
-
财政年份:2006
-
负责人:KATO Takuma
-
依托单位:
Effect of environmental chemicals on the Th1/Th2 development and exacerbation of airway hyperresponsiveness
-
批准号:15510046
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2003
-
负责人:KATO Takuma
-
依托单位:
Immunotoxicity of endocrine disruptors
-
批准号:13833003
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:KATO Takuma
-
依托单位:
海外基金